Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03923075Completed
Randomised, double-blind trial comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Onset of neuromuscular blockade. Started May 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03923075.